Diabetic foot ulcer.
Conditions
Interventions
Use of amniotic membrane extract in the treatment of diabetic foot ulcers.
Sponsors
Iranian academic center for education culture and research
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age 18 or older To be able and willing to provide consent letter and agree to comply with study procedures and follow-up evaluations Ulcer size>1 and <36 cm2 Ulcer duration of =4weeks No clinical signs of infection Serum creatinine<3·0 mg/dl Glycosylated haemoglobin (HbA1c)<12% Adequate circulation Ankle-brachial index (ABI) between 0·7 and 1·2 or having e a normal Doppler arterial
Exclusion criteria
Exclusion criteria: participating in another clinical trial Currently receiving radiation or chemotherapy known or suspected malignancy of current ulcer Diagnosis of autoimmune connective tissue disease Received a biomedical or topical growth factor for their wound within the previous 30 days Pregnant or breast feeding Sensitivity to drug uses Smoking and drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Side effectes. Timepoint: Every week. Method of measurement: Common Terminology Criteria for Adverse Events.;Wound healing rate. Timepoint: Every week. Method of measurement: AutoCAD software. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahin Jamshidi
Iran University of Medical Sciences
Outcome results
None listed